TimeTeller puts our internal clocks at the center of personalized medicine
techcrunch.com Oct 15, 2026

TimeTeller puts our internal clocks at the center of personalized medicine

AI-summarised brief · reviewed before publication

German startup TimeTeller has launched a saliva‑based circadian rhythm test kit aimed at personalizing cancer treatment timing. CEO Angela Relógio, a physicist‑engineer and former oncology researcher, warns that the kit is not a standalone treatment guide but a tool for clinical studies. The company, founded after her discovery linking side‑effects to treatment timing, has partnered with Techniker Krankenkasse to reimburse tests for cancer patients and plans to expand coverage to its 12 million members. TimeTeller’s goal is to improve treatment tolerability and outcomes by aligning therapy with patients’ internal clocks.

💡 Why It Matters

  • · By quantifying individual circadian patterns, TimeTeller offers a data‑driven approach that could shift oncology from a one‑size‑fits‑all schedule to precision timing, potentially reducing toxicity and enhancing efficacy.